Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 35 results.
User Information
Export Records
  1. 1.   Elevated Phosphate Activates N-ras and Promotes Cell Transformation and Skin Tumorigenesis
  2. Camalier, C. E.; Young, M. R.; Bobe, G.; Perella, C. M.; Colburn, N. H.; Beck, G. R.
  3. Cancer Prevention Research. 2010, Mar; 3(3): 359-370.
  1. 2.   Linoleic acid metabolite suppresses skin inflammation and tumor promotion in mice: possible roles of programmed cell death 4 induction
  2. Yasuda, M.; Nishizawa, T.; Ohigashi, H.; Tanaka, T.; Hou, D. X.; Colburn, N. H.; Murakami, A.
  3. Carcinogenesis. 2009 30(7): 1209-1216.
  1. 3.   Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects
  2. Robertson, S. M.; Maldarelli, F.; Natarajan, V.; Formentini, E.; Alfaro, R. M.; Penzak, S. R.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2008 49(5): 513-519.
  1. 4.   Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies
  2. Wei, Q.; Jiang, H.; Matthews, C. P.; Colburn, N. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(50): 19738-19743.
  1. 5.   Cytochrome P4502B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda
  2. Penzak, S. R.; Kabuye, G.; Mugyenyi, P.; Mbamanya, F.; Natarajan, V.; Alfaro, R. M.; Kityo, C.; Formentini, E.; Masur, H.
  3. HIV Medicine. 2007, Mar; 8(2): 86-91.
  1. 6.   Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo
  2. Brehm, M. A.; Daniels, K. A.; Ortaldo, J. R.; Welsh, R. M.
  3. Journal of Immunology. 2005, JUN 1; 174(11): 6663-6671.
  1. 7.   A paracrine signal mediates the cell transformation response to low dose gamma radiation in JB6 cells
  2. Weber, T. J.; Siegel, R. W.; Markille, L. M.; Chrisler, W. B.; Lei, X. Y. C.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2005, MAY; 43(1): 31-37.
  1. 8.   Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes
  2. Makrigiannis, A. P.; Patel, D.; Goulet, M. L.; Dewar, K.; Anderson, S. K.
  3. Genes and Immunity. 2005, MAR; 6(2): 71-83.
  1. 9.   Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappa B/p65 DNA binding
  2. Hu, J.; Colburn, N. H.
  3. Molecular Cancer Research. 2005, FEB; 3(2): 100-109.
  1. 10.   Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappa B activation and transformation in resistant JB6 cells
  2. Hu, J.; Nakano, H.; Sakurai, H.; Colburn, N. H.
  3. Carcinogenesis. 2004, OCT; 25(10): 1991-2003.
  1. 11.   Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms
  2. Hou, D. X.; Kai, K.; Li, J. J.; Lin, S. G.; Terahara, N.; Wakamatsu, M.; Fujii, M.; Young, M. R.; Colburn, N.
  3. Carcinogenesis. 2004 25(1): 29-36.
  1. 12.   Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease
  2. Gendelman, M.; Hecht, T.; Logan, B.; Vodanovic-Jankovic, S.; Komorowski, R.; Drobyski, W. R.
  3. Journal of Immunology. 2004 172(5): 3328-3336.
  1. 13.   Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation
  2. Dhar, A.; Hu, J.; Reeves, R.; Resar, L. M. S.; Colburn, N. H.
  3. Oncogene. 2004 23(25): 4466-4476.
  1. 14.   Development of a quantitative antigen-specific cell-based ELISA for the 7G7/B6 monoclonal antibody directed toward IL-2R alpha
  2. Yang, X. Y.; Jiang, H. G.; Hartmann, W. K.; Mitra, G.; Soman, G.
  3. Journal of Immunological Methods. 2003 277(1-2): 87-100.
  1. 15.   Nitric oxide does not mediate but inhibits transformation and tumor phenotype
  2. Dhar, A.; Brindley, J. M.; Stark, C.; Citro, M. L.; Keefer, L. K.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2003 2(12): 1285-1293.
  1. 16.   Promising molecular targets for cancer prevention: AP-1, NF- kappa B and Pdcd4
  2. Young, M. R.; Yang, H. S.; Colburn, N. H.
  3. Trends in Molecular Medicine. 2003 9(1): 36-41.
  1. 17.   The role of AP-1, NF-kappa B and ROS/NOS in skin carcinogenesis: The JB6 model is predictive
  2. Dhar, A.; Young, M. R.; Colburn, N. H.
  3. Molecular and Cellular Biochemistry. 2002 234(1): 185-193.
  1. 18.   Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently
  2. Young, M. R.; Nair, R.; Bucheimer, N.; Tulsian, P.; Brown, N.; Chapp, C.; Hsu, T. C.; Colburn, N. H.
  3. Molecular and Cellular Biology. 2002 22(2): 587-598.
  1. 19.   AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers
  2. Suzukawa, K.; Colburn, N. H.
  3. Oncogene. 2002 21(14): 2181-2190.
  1. 20.   A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappa B or ODC transactivation
  2. Yang, H. S.; Jansen, A. P.; Nair, R.; Shibahara, K.; Verma, A. K.; Cmarik, J. L.; Colburn, N. H.
  3. Oncogene. 2001 20(6): 669-676.
  1. 21.   Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappa B activation
  2. Hsu, T. C.; Nair, R.; Tulsian, P.; Camalier, C. E.; Hegamyer, G. A.; Young, M. R.; Colburn, N. H.
  3. Cancer Research. 2001 61(10): 4160-4168.
  1. 22.   cDNA cloning and mapping of mouse pleckstrin (Plek), a gene upregulated in transformation-resistant cells
  2. Cmarik, J. L.; Hegamyer, G.; Gerrard, B.; Dean, M.; Colburn, N. H.
  3. Genomics. 2000 66(2): 204-212.
  1. 23.   Activator protein 1 (AP-1)- and nuclear factor kappa B (NF-kappa B)-dependent transcriptional events in carcinogenesis
  2. Hsu, T. C.; Young, M. R.; Cmarik, J.; Colburn, N. H.
  3. Free Radical Biology and Medicine. 2000 28(9): 1338-1348.
  1. 24.   Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation
  2. Cmarik, J. L.; Min, H. Z.; Hegamyer, G.; Zhan, S. N.; Kulesz-Martin, M.; Yoshinaga, H.; Matsuhashi, S.; Colburn, N. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(24): 14037-14042.
  1. 25.   Vanadate-induced activation of activator protein-1: role of reactive oxygen species
  2. Ding, M.; Li, J. J.; Leonard, S. S.; Ye, J. P.; Shi, X. L.; Colburn, N. H.; Castranova, V.; Vallyathan, V.
  3. Carcinogenesis. 1999 20(4): 663-668.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel